Cours de l’action Zevra Therapeutics (ZVRA) aujourd’hui, pré-marché et after-hours

Donnée

Supercharts

Legend

Plus

Recherche

Zevra Therapeutics, Inc.

ZVRA

Nasdaq

Health Technology

Pharmaceuticals: Major

9.71

USD

+0.185

+1.94%

Fermé: 07-27 20:00 (UTC+0)

9.69

USD

-0.02

-0.21%

Après-clôture: 07-27 20:35 (UTC+0)

ZVRA Statistiques clés

Haut

9.99

Ouverture

9.53

Volume

1.51M

Bas

9.47

Clôture précédente

9.53

Valeur négociée

14.76M

Plus haut 52 sem.

15.04

Vol. relatif

0.961

Amplitude (%)

5.46%

Plus bas 52 sem.

7.16

Taux de rotation

2.57%

Cap. Marché

563.07M

PER (TTM)

4.42

PER (Annuel)

6.807

P/B

2.74

P/S

4.61

Bénéfice par action (BPA)

2.154

Dividende (TTM)

Rendement du dividende

0.00%

Actions en circulation

59.11M

Devise

USD

ZVRA Performance du Prix

7 jour

30 jour

90 jour

180 jour

Depuis le début de l’année

1 An

ZVRA Répartition des flux monétaires

ZVRA Volume quotidien des ventes à découvert

ZVRA Historique du short interest

ZVRA Aperçu de l’action

As of 2026-07-27, the Zevra Therapeutics, Inc. (ZVRA) stock price today is 9.71. Based on this price, the company has a market capitalization of $563.07M, with a P/E ratio of 4.42. On 2026-07-27, ZVRA traded between 9.47 and 9.99. Today’s stock price is 2.53% above the daily low and 2.80% below the daily high, placing ZVRA près du milieu de its most recent trading range. Trading volume currently stands at 1.51M, compared with an average daily volume of 1.58M. This suggests that trading activity is à peu près conforme à son niveau habituel than usual. Over the past year, Zevra Therapeutics, Inc. shares have traded between 7.16 and 15.04. At today’s price, ZVRA is 35.61% above its 52-week low and 35.44% below its 52-week high.

ZVRA Actualités liées

À propos ZVRA

Nom l'entreprise

Zevra Therapeutics, Inc.

Secteur

Health Technology

Industrie

Pharmaceuticals: Major

Exchanges

Nasdaq

Nombre d’employés

Taille du lot

100

Site officiel

www.zevra.com

Devise

USD

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Related Stocks

ZVRA FAQ

1.What is the live stock price of Zevra Therapeutics, Inc. (ZVRA) today?

3. What is the latest pre-market price of ZVRA?

5.How has ZVRA’s stock price performed recently?

7. What is the current capital flow for ZVRA?

9. What is the current price of NVDA stock perps?

11. What is the market capitalization of Zevra Therapeutics, Inc.?

13. What is Zevra Therapeutics, Inc.’s earnings per share (EPS)?

15. Does Zevra Therapeutics, Inc. pay dividends?

17. How many employees does Zevra Therapeutics, Inc. have?

2. What were ZVRA’s trading range and trading volume on the most recent trading day?

4.What is ZVRA’s after-hours price?

6. What are ZVRA’s 52-week high and 52-week low?

8. What are ZVRA’s short sale volume and short interest?

10. What are Zevra Therapeutics, Inc.’s P/E ratio and valuation metrics?

12. What were Zevra Therapeutics, Inc.’s revenue and net income in the most recent quarter?

14.What is Zevra Therapeutics, Inc.’s total number of shares outstanding?

16. Which exchange is Zevra Therapeutics, Inc. listed on, and what sector and industry does it belong to?

18. What risks should investors consider before investing in ZVRA?